Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI  

作　　者：Ryan L.Brunsing Kathryn J.Fowler Takeshi Yokoo Guilherme Moura Cunha Claude B.Sirlin Robert M.Marks 

机构地区：[1]Department of Radiology,Stanford University,Stanford,CA 94305,USA [2]Liver Imaging Group,Department of Radiology,University of California San Diego,San Diego,CA 92093,USA [3]Department of Radiology,University of Texas Southwestern Medical Center,Dallas,TX 75390,USA [4]Department of Radiology,Naval Medical Center San Diego,San Diego,CA 92134,USA [5]Department of Radiology,Uniformed Services University of the Health Sciences,Bethesda,MD 20892,USA.

出　　处：《Hepatoma Research》2020年第9期39-54,共16页肝癌研究（英文版）

基　　金：supported in part by NIH(1R01CA249765-01).

摘　　要：This review focuses on emerging abbreviated magnetic resonance imaging(AMRI)surveillance of patients with chronic liver disease for hepatocellular carcinoma(HCC).This surveillance strategy has been proposed as a high-sensitivity alternative to ultrasound for identification of patients with early-stage HCC,particularly in patients with cirrhosis or obesity,in whom sonographic visualization of small tumors may be compromised.Three general AMRI approaches have been developed and studied in the literature-non-contrast AMRI,dynamic contrast-enhanced AMRI,and hepatobiliary phase contrast-enhanced AMRI-each comprising a small number of selected sequences specifically tailored for HCC detection.The rationale,general technique,advantages and disadvantages,and diagnostic performance of each AMRI approach is explained.Additionally,current gaps in knowledge and future directions are discussed.Based on emerging evidence,we cautiously recommend the use of AMRI for HCC surveillance in situations where ultrasound is compromised.

关 键 词：Abbreviated magnetic resonance imaging CIRRHOSIS Hepatitis B hepatocellular carcinoma SURVEILLANCE magnetic resonance imaging 

分 类 号：R73[医药卫生—肿瘤]